BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

IPAR: Sales Trajectory Ahead of Estimates

IPAR: 2024 in the Spotlight, Target Now $172

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>IPAR continued to experience momentum in demand in the second quarter with preliminary sales ending up at $309 million compared to our Street high estimate of $283.7 million</li>
<li>IPAR’s management is taking a conservative approach with sales forecast given the supply chain and sales volatility in certain regions. </li>
<li>The strength in second quarter sales was across multiple brands and in both segments</li>
</ul>


IPAR continued to experience momentum in demand in the second quarter with preliminary sales ending up at $309 million compared to our Street high estimate of $283.7 million
IPAR’s management is taking a conservative approach with sales forecast given the supply chain and sales volatility in certain regions. 
The strength in second quarter sales was across multiple brands and in both segments


Inter Parfums

IPAR: Adding and Growing